Patent ID: 7342005

Claim:
A pharmaceutical formulation for intravenous, subcutaneous or intra-muscular injection comprising a compound of the formula (I) or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof and a pharmaceutically acceptable injectable carrier, wherein: R 1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R 2 is hydrogen or C 1-4 alkyl; R 3 is hydrogen or C 1-4 alkyl; R 4 and R 5 are the same or different and are selected from hydrogen, halo, cyano, C 1-4 alkyl, nitro, hydroxy, carboxy, C 1-4 alkoxy, C 1-4 alkoxycarbonyl, aminosulphonyl, C 1-4 alkylaminosulphonyl, di-C 1-4 -alkylaminosulphonyl, carbamoyl, C 1-4 alkylcarbamoyl, di-C 1-4 alkylcarbamoyl, trifluoromethyl, sulphonic acid, amino, C 1-4 alkylamino, di-C 1-4 alkylamino, C 1-4 alkanoylamino, C 1-4 alkanoyl( N —C 1-4 alkyl)amino, C 1-4 alkanesulphonamido and —S(O) n C 1-4 alkyl and wherein n is zero, one or two; with the proviso that there is no hydroxy or carboxy substituent in a position ortho to the link to —NR 3 —.